POSC256 Application of Progression-Free Survival As Surrogate Endpoint for Overall Survival in Nice Reviews of Advanced Breast Cancer Drugs

Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.894
https://www.valueinhealthjournal.com/article/S1098-3015(21)02689-9/fulltext
Section Title :
Section Order : 10421
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02689-9&doi=10.1016/j.jval.2021.11.894
HEOR Topics :
Tags :
Regions :